POINT Biopharma Global Inc. - Common Stock (NQ:PNT)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Dec 26, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about POINT Biopharma Global Inc. - Common Stock

< Previous 1 2 3 4 Next >

Recent M&A Bodes Well For Targeted Cancer Therapy Player Fusion Pharmaceuticals, Analyst Say AstraZeneca Is Favorably Positioned ↗

December 27, 2023

With recent merger and acquisition deals in the targeted radiopharmaceutical therapy (TRT) space, on Tuesday, Oppenheimer noted that Fusion Pharmaceuticals Inc (NASDAQ: FUSN) is potentially the sole...

Via Benzinga

Lantheus Downgraded Due To Reliance On PNT2002; Analyst Cites Comparable Profile To Novartis' Drug ↗

December 19, 2023

Monday, Lantheus Holdings Inc (NASDAQ: LNTH) and POINT Biopharma Global Inc (NASDAQ: PNT) reported topline data from pivotal Phase 3 SPLASH trial of 177Lu-PNT2002 in metastatic c

Via Benzinga

Why is Prostate Cancer Focused Lantheus Stock Trading Lower Today? ↗

December 18, 2023

Lantheus Holdings Inc (NASDAQ: LNTH) and POINT Biopharma Global Inc (NASDAQ: PNT) reported topline data from pivotal Phase 3 SPLASH trial of 177Lu-PNT2002 in metastatic castration-res

Via Benzinga

Improving Survival Rates: Biotech Innovations in Pancreatic Cancer Treatment

November 29, 2023

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:EXEL),(NASDAQ:MRTX),(NYSE:LLY),(NASDAQ:PNT) EQNX::TICKER_END

Via FinancialNewsMedia

Topics Death

Recap: POINT Biopharma Global Q3 Earnings ↗

November 13, 2023

Via Benzinga

Top 5 Health Care Stocks That May Collapse In November ↗

November 17, 2023

As of Nov. 17, 2023, five stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Via Benzinga

7 Healthcare Stocks That Are Poised to Become the Next Unicorns ↗

November 09, 2023

Discover healthcare stocks with remarkable potential for growth and "unicorn" status in the ever-evolving world of healthcare investments.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2023 ↗

October 24, 2023

Via Benzinga

Bristol Myers Squibb Enters the Multi-Billion-Dollar Oncology Race

October 17, 2023

Major pharmaceutical companies are continuing to make substantial acquisitions in the field of oncology, sparking enthusiasm in the market. Bristol Myers Squibb (NYSE:BMY) just announced its plan to...

Via PressReach

POINT BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of POINT Biopharma Global, Inc. - PNT

October 06, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

Stock Market Ends On High Note Even As Yields Soar; Tesla In Focus: Weekly Review ↗

October 06, 2023

A rally attempt continues amid soaring Treasury yields.

Via Investor's Business Daily

Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2023 ↗

October 06, 2023

Via Benzinga

Why Point BioPharma Global Stock Skyrocketed 86% This Week ↗

October 05, 2023

Point Biopharma is being acquired by Eli Lilly. Here's what investors need to know.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For October 4, 2023 ↗

October 04, 2023

Via Benzinga

Why Eli Lilly Stock Was Looking Sickly Today ↗

October 03, 2023

Investors weren't necessarily satisfied with their company's latest asset buy.

Via The Motley Fool

Crude Oil Moves Higher; POINT Biopharma Global Shares Jump ↗

October 03, 2023

U.S. stocks extended losses toward the end of trading, with the S&P 500 falling around 1.5% on Tuesday. The Dow traded down 1.43% to 32,954.84 while the NASDAQ fell 1.98% to 13,044.24. The S&P 500 also...

Via Benzinga

Topics Stocks

Why Shares of Point Biopharma Global Are Soaring Tuesday ↗

October 03, 2023

The company entered into a buyout agreement with Eli Lilly.

Via The Motley Fool

Why Getty Images Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

October 03, 2023

Gainers Vericity, Inc. (NASDAQ: VERY) shares climbed 87.4% to $11.12 after iA Financial Group announced it will acquire the company.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 03, 2023

Via Benzinga

Nasdaq Down Over 200 Points; US Job Openings Rise In August ↗

October 03, 2023

U.S. stocks extended losses midway through trading, with the Nasdaq Composite falling more than 200 points on Tuesday. The Dow traded down 1.06% to 33,078.27 while the NASDAQ fell 1.60% to 13,094.83....

Via Benzinga

Topics Stocks

Point Biopharma Stock Nearly Doubles On Eli Lilly Deal ↗

October 03, 2023

Eli Lilly is spending $1.4 billion on buying Point Biopharma Global Inc. Point Biopharma is a radiopharmaceutical company focused on cancer treatment.

Via Talk Markets

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Vericity, Inc. (Nasdaq - VERY), POINT Biopharma Global, Inc. (Nasdaq - PNT), Blue Apron Holdings, Inc. (Nasdaq - APRN), Chico’s FAS, Inc. (NYSE - CHS)

October 03, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

'Airbnb Has Foundational Cracks', Disney+ Follows Netflix On Subscription Sharing Crackdown, Microsoft's Nadella Criticizes Google's Exclusive Content Deals: Today's Top Stories ↗

October 03, 2023

Benzinga

Via Benzinga

Vericity, POINT Biopharma Global, Oddity Tech And Other Big Stocks Moving Higher On Tuesday ↗

October 03, 2023

U.S. stocks traded lower, with the Nasdaq Composite falling more than 100 points on Tuesday. Here are some big stocks recording gains in today’s session. Vericity, Inc. (NASDAQ: VERY) shares climbed...

Via Benzinga

Topics Stocks

Dow Falls Over 100 Points; McCormick Sales Miss Views ↗

October 03, 2023

U.S. stocks traded lower this morning, with the Dow Jones falling more than 100 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.37% to 33,310.99 while the NASDAQ fell...

Via Benzinga

Topics Earnings Stocks

Point Biopharma Stock Launches 84% On Eli Lilly's $1.4 Billion Takeover ↗

October 03, 2023

The company is working on targeted radiation therapy with prostate cancer results up next.

Via Investor's Business Daily

HPQ Stock Alert: HP Just Scored a Double Upgrade From Bank of America ↗

October 03, 2023

HP is in the news Tuesday after shares of HPQ stock got a double upgrade and price target increase from Bank of America this morning!

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 03, 2023

Via Benzinga

Why Is Cancer Treatment Focused POINT Biopharma Stock Trading Higher Today? ↗

October 03, 2023

Eli Lilly And Co (NYSE: LLY) agreed to acquire POINT Biopharma Global Inc (NASDAQ: PNT) at $12.50 per share in cash, an aggregate of

Via Benzinga

Why Is Point Biopharma (PNT) Stock Up 84% Today? ↗

October 03, 2023

Point Biopharma stock is heading higher on Tuesday as investors react to news of Eli Lilly acquiring the shares of PNT for $12.50 each.

Via InvestorPlace

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.